Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy

Ahern, 2002, cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO, Trends Neurosci., 25, 510, 10.1016/S0166-2236(02)02254-3 Arancio, 2001, Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation, J. Neurosci., 21, 143, 10.1523/JNEUROSCI.21-01-00143.2001 Azad, 2001, Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse, Eur. J. Neurosci., 13, 561, 10.1046/j.1460-9568.2001.01431.x Bahremand, 2009, Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice, Epilepsy Res., 84, 110, 10.1016/j.eplepsyres.2009.01.003 Bolognini, 2012, AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor, Br. J. Pharmacol., 165, 2561, 10.1111/j.1476-5381.2011.01503.x Braakman, 2009, Rimonabant induces partial seizures in a patient with a history of generalized epilepsy, Epilepsia, 50, 2171, 10.1111/j.1528-1167.2009.02203.x Burette, 2002, Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus, J. Neurosci., 22, 8961, 10.1523/JNEUROSCI.22-20-08961.2002 Cabral, 2008, CB2 receptors in the brain: role in central immune function, Br. J. Pharmacol., 153, 240, 10.1038/sj.bjp.0707584 Carletti, 2013, Antiepileptic effect of dimethyl sulfoxide in a rat model of temporal lobe epilepsy, Neurosci. Lett., 546, 31, 10.1016/j.neulet.2013.04.031 Castillo, 2012, Endocannabinoid signaling and synaptic function, Neuron, 76, 70, 10.1016/j.neuron.2012.09.020 Chevaleyre, 2006, Endocannabinoid-mediated synaptic plasticity in the CNS, Annu. Rev. Neurosci., 29, 37, 10.1146/annurev.neuro.29.051605.112834 Deadwyler, 1995, Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process, J. Pharmacol. Exp. Ther., 273, 734 den Boon, 2012, Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors, Proc. Natl. Acad. Sci. U.S.A., 109, 3534, 10.1073/pnas.1118167109 Deshpande, 2007, Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy, Neurosci. Lett., 411, 11, 10.1016/j.neulet.2006.09.046 Devane, 1988, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34, 605 Feil, 2008, NO/cGMP-dependent modulation of synaptic transmission, Handb. Exp. Pharmacol., 184, 529, 10.1007/978-3-540-74805-2_16 Fernández-Ruiz, 2007, Cannabinoid CB2 receptor: a new target for controlling neural cell survival?, Trends Pharmacol. Sci., 28, 39, 10.1016/j.tips.2006.11.001 García-Gutiérrez, 2012, Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors, Br. J. Pharmacol., 165, 951, 10.1111/j.1476-5381.2011.01625.x Ghasemi, 2007, Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats, Br. J. Pharmacol., 151, 591, 10.1038/sj.bjp.0707279 Gong, 2006, Cannabinoid CB2 receptors: immunohistochemical localization in rat brain, Brain Res., 1071, 10, 10.1016/j.brainres.2005.11.035 Hill, 2013, Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism, Br. J. Pharmacol., 170, 679, 10.1111/bph.12321 Hofmann, 2013, Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention, Exp. Neurol., 244, 43, 10.1016/j.expneurol.2011.11.047 Howlett, 2004, Cannabinoid physiology and pharmacology: 30 years of progress, Neuropharmacology, 47, 345, 10.1016/j.neuropharm.2004.07.030 Jones, 2008, Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells, Neuropharmacology, 54, 23, 10.1016/j.neuropharm.2007.06.027 Jones, 2012, Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures, Seizure, 21, 344, 10.1016/j.seizure.2012.03.001 Kreitzer, 2001, Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells, Neuron, 29, 717, 10.1016/S0896-6273(01)00246-X Llano, 1991, Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents, Neuron, 6, 565, 10.1016/0896-6273(91)90059-9 Maggi, 1986, Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 1: General considerations, Experientia, 42, 109, 10.1007/BF01952426 Makara, 2007, Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors, J. Neurosci., 27, 10211, 10.1523/JNEUROSCI.2104-07.2007 Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0 Mergia, 2009, Genetic mouse models of the NO receptor ‘soluble’ guanylyl cyclases, Handb. Exp. Pharmacol., 191, 33, 10.1007/978-3-540-68964-5_3 Monory, 2006, The endocannabinoid system controls key epileptogenic circuits in the hippocampus, Neuron, 51, 455, 10.1016/j.neuron.2006.07.006 Morgan, 2009, Functional CB2 type cannabinoid receptors at CNS synapses, Neuropharmacology, 57, 356, 10.1016/j.neuropharm.2009.07.017 Mukherjee, 2004, Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors, Eur. J. Pharmacol., 505, 1, 10.1016/j.ejphar.2004.09.058 Neitz, 2011, Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus, Eur. J. Neurosci., 33, 1611, 10.1111/j.1460-9568.2011.07654.x Pan, 1996, Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system, Mol. Pharmacol., 49, 707 Paxinos, 1986 Rizzo, 2009, Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat, Neurosc. Lett., 462, 135, 10.1016/j.neulet.2009.07.014 Robello, 1996, Nitric oxide and GABAA receptor function in the rat cerebral cortex and cerebellar granule cells, Neuroscience, 74, 99, 10.1016/0306-4522(96)00110-8 Sardo, 2006, Involvement of nitric oxide-soluble guanylyl cyclase pathway in the control of maximal dentate gyrus activation in the rat, J. Neural Transm., 113, 1855, 10.1007/s00702-006-0491-9 Sardo, 2008, Lamotrigine differently modulates 7-nitroindazole and l-arginine influence on rat maximal dentate gyrus activation, J. Neural Transm., 115, 27, 10.1007/s00702-007-0824-3 Stefano, 1998, Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues, Brain Res., 793, 341, 10.1016/S0006-8993(98)00273-X Stringer, 1995, In the hippocampus in vivo, nitric oxide does not appear to function as an endogenous antiepileptic agent, Exp. Brain Res., 105, 391 Stringer, 1989, Maximal dentate gyrus activation: characteristics and alterations after repeated seizures, J. Neurophysiol., 62, 136, 10.1152/jn.1989.62.1.136 Van Sickle, 2005, Identification and functional characterization of brainstem cannabinoid CB2 receptors, Science, 310, 329, 10.1126/science.1115740 Wallace, 2003, The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy, J. Pharmacol. Exp. Ther., 307, 129, 10.1124/jpet.103.051920 Wilson, 2001, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses, Nature, 410, 588, 10.1038/35069076